Citation Impact
Citing Papers
Guidelines for the Prevention of Stroke in Patients With Stroke and Transient Ischemic Attack
2014 Standout
Cancer Risk in Diabetic Patients Treated with Metformin: A Systematic Review and Meta-analysis
2012
Liraglutide and Cardiovascular Outcomes in Type 2 Diabetes
2016 Standout
ADMET in silico modelling: towards prediction paradise?
2003
Oral Erythromycin and the Risk of Sudden Death from Cardiac Causes
2004
The influence of lipophilicity in drug discovery and design
2012
hERG potassium channels and cardiac arrhythmia
2006 Nature
How many drug targets are there?
2006 Standout
Receptor systems: Will mining the receptorome yield novel targets for pharmacotherapy?
2005
Rationale and Design of the Glycemia Reduction Approaches in Diabetes: A Comparative Effectiveness Study (GRADE)
2013
Incretins, Diabetes, Pancreatitis and Pancreatic Cancer: What the GI specialist needs to know
2015
Catalytic applications of layered double hydroxides: recent advances and perspectives
2014 Standout
Exercise Standards for Testing and Training
2013 Standout
A review of dry (CO2) reforming of methane over noble metal catalysts
2014 Standout
QT Correction Methods in Children and Adolescents
2005
New insights about HERG blockade obtained from protein modeling, potential energy mapping, and docking studies
2006
Nanoparticles as Recyclable Catalysts: The Frontier between Homogeneous and Heterogeneous Catalysis
2005 Standout
Acute Pancreatitis
2016 Standout
A structure-based computational workflow to predict liability and binding modes of small molecules to hERG
2020 StandoutNobel
ORAL MITEMCINAL (GM‐611), AN ERYTHROMYCIN‐DERIVED PROKINETIC, ACCELERATES NORMAL AND EXPERIMENTALLY DELAYED GASTRIC EMPTYING IN CONSCIOUS DOGS
2007 StandoutNobel
Antibody therapy of cancer
2012 Standout
How to improve R&D productivity: the pharmaceutical industry's grand challenge
2010 Standout
Natural products to drugs: natural product-derived compounds in clinical trials
2008 Standout
Cardiovascular toxicity of molecularly targeted agents
2009
The application of discovery toxicology and pathology towards the design of safer pharmaceutical lead candidates
2007
Treatment of nausea and vomiting: Gaps in our knowledge
2006
Can we rationally design promiscuous drugs?
2006
The use of pioglitazone and the risk of bladder cancer in people with type 2 diabetes: nested case-control study
2012
Type 2 diabetes
2017 Standout
Modulating peroxisome proliferator–activated receptors for therapeutic benefit? Biology, clinical experience, and future prospects
2012
Myocarditis
2011 Standout
Chemotherapy-Induced Nausea and Vomiting
2008 Standout
Anticancer drugs and cardiotoxicity: Insights and perspectives in the era of targeted therapy
2009
In vitro pharmacologic testing using human induced pluripotent stem cell-derived cardiomyocytes
2009 StandoutNobel
MITEMCINAL (GM‐611), AN ORALLY ACTIVE MOTILIN RECEPTOR AGONIST, IMPROVES DELAYED GASTRIC EMPTYING IN A CANINE MODEL OF DIABETIC GASTROPARESIS
2008 StandoutNobel
PPARγ signaling and metabolism: the good, the bad and the future
2013 Standout
Antibacterial Natural Products in Medicinal Chemistry—Exodus or Revival?
2006
Computational investigations of hERG channel blockers: New insights and current predictive models
2015
Relating protein pharmacology by ligand chemistry
2007 Standout
A two-state homology model of the hERG K+ channel: application to ligand binding
2005
SwissADME: a free web tool to evaluate pharmacokinetics, drug-likeness and medicinal chemistry friendliness of small molecules
2017 Standout
vNN Web Server for ADMET Predictions
2017
Natural products to drugs: natural product derived compounds in clinical trials
2005
Understanding the hepatitis C virus life cycle paves the way for highly effective therapies
2013 StandoutNobel
Revisiting STAT3 signalling in cancer: new and unexpected biological functions
2014 Standout
Medication Adherence: WHO Cares?
2011 Standout
Assessing the proarrhythmic potential of drugs: Current status of models and surrogate parameters of torsades de pointes arrhythmias
2006
Exploring blocker binding to a homology model of the open hERG K+ channel using docking and molecular dynamics methods
2005
Novel Bayesian classification models for predicting compounds blocking hERG potassium channels
2014
Pioglitazone use and the risk of bladder cancer
2013
Thiazolidinediones and the Promise of Insulin Sensitization in Type 2 Diabetes
2014
Prediabetes: a high-risk state for diabetes development
2012 Standout
Effects of Oral Mitemcinal (GM-611), Erythromycin, EM-574 and Cisapride on Gastric Emptying in Conscious Rhesus Monkeys
2007
Overcoming HERG affinity in the discovery of the CCR5 antagonist maraviroc
2006
New opportunities in anti-hepatitis C virus drug discovery: Targeting NS4B
2011
Does a Single-Pill Antihypertensive/Lipid-Lowering Regimen Improve Adherence in US Managed Care Enrolees?
2010
4-Fluorosulfonylpiperidines: Selective 5-HT2A ligands for the treatment of insomnia
2005
Acquired QT interval prolongation and HERG: implications for drug discovery and development
2004
Myocarditis
2009 Standout
2021 Guideline for the Prevention of Stroke in Patients With Stroke and Transient Ischemic Attack: A Guideline From the American Heart Association/American Stroke Association
2021 Standout
Fluorine in medicinal chemistry
2007 Standout
Fluorine in Pharmaceutical Industry: Fluorine-Containing Drugs Introduced to the Market in the Last Decade (2001–2011)
2013 Standout
Medicinal Chemistry of hERG Optimizations: Highlights and Hang-Ups
2006
Catalytic partial oxidation of methane over a 4% Rh/α-Al2O3 catalyst Part II: Role of CO2 reforming
2008
pkCSM: Predicting Small-Molecule Pharmacokinetic and Toxicity Properties Using Graph-Based Signatures
2015 Standout
Magnesium in Man: Implications for Health and Disease
2014 Standout
Management of Hyperglycemia in Type 2 Diabetes, 2015: A Patient-Centered Approach: Update to a Position Statement of the American Diabetes Association and the European Association for the Study of Diabetes
2014 Standout
Is There a Link Between Liraglutide and Pancreatitis? A Post Hoc Review of Pooled and Patient-Level Data From Completed Liraglutide Type 2 Diabetes Clinical Trials
2014
Computational Design and Discovery of “Minimally Structured” hERG Blockers
2012
Deep Learning-Based Prediction of Drug-Induced Cardiotoxicity
2019
The Hitchhiker’s Guide to Flow Chemistry
2017 Standout
ACC/AHA/ESC 2006 Guidelines for Management of Patients With Ventricular Arrhythmias and the Prevention of Sudden Cardiac Death
2006
Docking and scoring in virtual screening for drug discovery: methods and applications
2004 Standout
Next Generation of Fluorine-Containing Pharmaceuticals, Compounds Currently in Phase II–III Clinical Trials of Major Pharmaceutical Companies: New Structural Trends and Therapeutic Areas
2016 Standout
Development and Evaluation of an in Silico Model for hERG Binding
2005
NRF2 activation by antioxidant antidiabetic agents accelerates tumor metastasis
2016
The diagnosis and management of nonalcoholic fatty liver disease: Practice guidance from the American Association for the Study of Liver Diseases
2017 Standout
Nanotechnology for Multimodal Synergistic Cancer Therapy
2017 Standout
High stability of Ce-promoted Ni/Mg–Al catalysts derived from hydrotalcites in dry reforming of methane
2009
Dietary and Policy Priorities for Cardiovascular Disease, Diabetes, and Obesity
2016 Standout
Identification of AP80978, a Novel Small-Molecule Inhibitor of Hepatitis C Virus Replication That Targets NS4B
2014 StandoutNobel
Extra Precision Glide: Docking and Scoring Incorporating a Model of Hydrophobic Enclosure for Protein−Ligand Complexes
2006 Standout
Sustainable Conversion of Carbon Dioxide: An Integrated Review of Catalysis and Life Cycle Assessment
2017 Standout
Fluorine in Pharmaceuticals: Looking Beyond Intuition
2007 StandoutScience
Structure-based discovery of β 2 -adrenergic receptor ligands
2009 StandoutNobel
The KEAP1-NRF2 System: a Thiol-Based Sensor-Effector Apparatus for Maintaining Redox Homeostasis
2018 Standout
Generation of a Set of Simple, Interpretable ADMET Rules of Thumb
2008
Beyond Established and Novel Risk Factors
2008
ADMETlab 2.0: an integrated online platform for accurate and comprehensive predictions of ADMET properties
2021 Standout
Metal–Organic Frameworks in Biomedicine
2011 Standout
Development of Safe Drugs: The hERG Challenge
2017
Pd nanoparticles in hydrotalcite: mild and highly selective catalysts for alkyne semihydrogenation
2003
A Multiscale Simulation System for the Prediction of Drug-Induced Cardiotoxicity
2011
Sustainable Flow Oppenauer Oxidation of Secondary Benzylic Alcohols with a Heterogeneous Zirconia Catalyst
2013
Part 14: Pediatric Advanced Life Support
2010 Standout
Photopharmacology: Beyond Proof of Principle
2014 StandoutNobel
Mechanism of reconstitution of hydrotalcite leading to eggshell-type Ni loading on MgAl mixed oxide
2005
AHA/ACCF/HRS Recommendations for the Standardization and Interpretation of the Electrocardiogram
2009 Standout
hERG liability classification models using machine learning techniques
2019
ATP-sensitive potassium channel (K ATP )–dependent regulation of cardiotropic viral infections
2011 StandoutNobel
Works of Elisabetta Poluzzi being referenced
Adherence to chronic cardiovascular therapies: persistence over the years and dose coverage
2006
The hERG K+ channel: target and antitarget strategies in drug development
2008
Safety of Non-Antiarrhythmic Drugs that Prolong the QT Interval or Induce Torsade de Pointes
2002
Clinical implications of enteric and central D2 receptor blockade by antidopaminergic gastrointestinal prokinetics
2004
QT prolongation through hERG K+ channel blockade: Current knowledge and strategies for the early prediction during drug development
2004
Non‐antiarrhythmic drugs prolonging the QT interval:considerable use in seven countries
2002
The association of pancreatitis with antidiabetic drug use: gaining insight through the FDA pharmacovigilance database
2011
Adherence to statin therapy and patients’ cardiovascular risk: a pharmacoepidemiological study in Italy
2008
Organising evidence on QT prolongation and occurrence of Torsades de Pointes with non-antiarrhythmic drugs: a call for consensus
2001
Antibacterial macrolides: a drug class with a complex pharmacological profile
2004
QT-interval prolongation by non-cardiac drugs: lessons to be learned from recent experience
2000
Oppenauer's oxidation by paraformaldehyde of piperonyl alcohol to heliotropine
2008
Toward a Pharmacophore for Drugs Inducing the Long QT Syndrome: Insights from a CoMFA Study of HERG K+ Channel Blockers
2002
Catalytic partial oxidation and CO2-reforming on Rh- and Ni-based catalysts obtained from hydrotalcite-type precursors
1998
Adverse cardiovascular events associated with triptans and ergotamines for treatment of migraine: Systematic review of observational studies
2014
Assessing the Association of Pioglitazone Use and Bladder Cancer Through Drug Adverse Event Reporting
2011